Tencent has led a series C round for the health e-commerce company, which will use the cash to bolster its business and technology development efforts.
Month: April 2018
Reflexion contemplates $100m series C
Pfizer and Johnson & Johnson were among the returning backers to support a $100m series C round for Reflexion Medical, which secured the Rise Fund as lead investor.
Joaug joins Aster as principal
Serial entrepreneur Je?rome Joaug has joined Aster Capital, the venture capital firm that emerged out of Schneider Electric Ventures.
Von Richter banks on LBBW Ventures role
Andreas von Richter had previously been partner of Aster Capital among other venture roles over the past decade.
Sheffer replaces Prior at GM Ventures
Prior to joining GM Ventures, Sheffer was executive director of chassis purchasing at US-based car maker General Motors.
Lee emerges at Unblock after IDG Ventures Korea
Lee had left IDG Ventures Korea in early 2016 and has spent the past near-two years as managing partner of Cognitive Investment.
Granath calls up Swisscanto from Telia
Granath had been responsible for the growth investment portfolio of Division X at Telia for three years.
Rothe switches from Capnamic to Iris
Rothe had spent five years at Capnamic, which includes Axa, Cewe, Cisco, Defacto, Euroweb, Gauselmann Die Spielemacher, Hahn Air, Helaba, MGO Digital Ventures, Muellermedien, NWZ Digital, Rheinische Post, Universal Music Group and DuMont Digital as its corporate limited partners in its funds.
Schnell moves quickly to head private equity
As CEO of Siemens Venture Capital until the creation of its Next47 corporate venturing unit last March, Schnell had included advisory services to its in-house pension fund.
Ola solves Ridlr acquisition
Ola has acquired Times Internet-backed public transportation app developer Ridlr in an all-stock deal reportedly worth almost $50m.
SalesLoft moves into $50m series C
SalesLoft has raised a total of $76m in funding after securing $50m in a series C round that included LinkedIn.
Investors approve $50m Accolade funding
Accolade has raised $50m from a consortium of investors that included McKesson Ventures, which previously injected $22.5m in 2015.
Twist wraps up $50m investment
Twist Bioscience, a US-based producer of synthetic DNA backed by corporates Kangmei, Illumina, WuXi PharmaTech and Institut Mérieux, raised $50m in funding on Monday from unnamed investors. Founded in 2013, Twist has developed a silicon-based DNA synthesis platform that has applications in areas such as healthcare, agriculture, industrial chemicals and data storage. The funding will… Continue reading Twist wraps up $50m investment
Mixpace steps into $63m series B1
Zhongnan has contributed to the series B1 round, having previously backed a series A, as co-working spaces provider Mixpace prepares to expand into additional cities.